News
New data shows improved prophylactic effectiveness with Sobi’s Elocta
Positive results from the Elocta study – A-SURE – have been presented at the 30th International Society on Thrombosis and Haemostasis (ISTH) Congress in London.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Positive results from the Elocta study – A-SURE – have been presented at the 30th International Society on Thrombosis and Haemostasis (ISTH) Congress in London.